Y020-4458 Screening compound: 3'-[3-(morpholin-4-yl)propyl]-1,2,3',4'-tetrahydro-1'H-spiro[indole-3,2'-quinazoline]-2,4'-dione

Y020-4458 Screening compound: 3'-[3-(morpholin-4-yl)propyl]-1,2,3',4'-tetrahydro-1'H-spiro[indole-3,2'-quinazoline]-2,4'-dione
Y020-4458 Screening compound: 3'-[3-(morpholin-4-yl)propyl]-1,2,3',4'-tetrahydro-1'H-spiro[indole-3,2'-quinazoline]-2,4'-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-4458
3'-[3-(morpholin-4-yl)propyl]-1,2,3',4'-tetrahydro-1'H-spiro[indole-3,2'-quinazoline]-2,4'-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-4458

Molecular Formula

C22H24N4O3 (C22 H24 N4 O3)

Compound Name

3'-[3-(morpholin-4-yl)propyl]-1,2,3',4'-tetrahydro-1'H-spiro[indole-3,2'-quinazoline]-2,4'-dione

IUPAC name

3'-[3-(morpholin-4-yl)propyl]-123'4'-tetrahydro-1'H-spiro[indole-32'-quinazoline]-24'-dione

SMILES

O=C(C1(Nc2c3cccc2)N(CCCN2CCOCC2)C3=O)Nc2c1cccc2

InChI

InChI=1S/C22H24N4O3/c27-20-16-6-1-3-8-18(16)24-22(17-7-2-4-9-19(17)23-21(22)28)26(20)11-5-10-25-12-14-29-15-13-25/h1-4,6-9,24H,5,10-15H2,(H,23,28)/t22-/m0/s1

InChI Key

KXNVHSUFEUSDHI-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD13758530

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

392.46

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.309

Distribution Coefficient, logD

2.175

Water Solubility, LogSw

-3.01

Polar Surface Area

64.293

Acid Dissociation Constant (pKa)

11.52

Base Dissociation Constant (pKb)

6.96

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.40

Y020-4458 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with Y020-4458 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-4458?
Check Price and Availability of Y020-4458, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-4458 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-4458
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-4458
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-4458 available by request